TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A study of more than 400,000 UK Biobank participants found that people with cardiometabolic disease who reported healthier sleep had slightly better cognitive test results and larger brain volumes than those with the same conditions who slept poorly. The findings show an association, not proof that better sleep prevents cognitive decline or dementia.
A study led by researchers at Karolinska Institutet found that people with type 2 diabetes, heart disease or stroke who reported healthier sleep performed slightly better on several cognitive tests and had larger brain volumes than people with the same conditions who slept poorly. Published in the Journal of the American Heart Association, the findings describe an association; they do not establish that improving sleep prevents brain changes or dementia.
The researchers analyzed data from more than 400,000 middle-aged and older UK Biobank participants. Just over 54,000 had at least one of the cardiometabolic conditions studied. Brain MRI scans were available for nearly 35,000 participants. The study examined whether sleep was related to cognitive performance and brain structure among people with these conditions.
Sleep was assessed using five self-reported factors: sleep duration, circadian rhythm, insomnia, snoring and daytime sleepiness. Participants with cardiometabolic disease and healthier sleep performed slightly better on tests of general cognition, problem-solving and processing speed than those with the same diseases and poorer sleep.
In the MRI data, the healthier-sleep group also had larger total brain volume and greater volumes of grey and white matter. The reported relationship between sleep and brain structure was more pronounced among people with type 2 diabetes, heart disease or stroke than among participants without those conditions. The study does not show that sleep alone caused these differences.
Sleep and Brain Health Risks
Type 2 diabetes, heart disease and stroke are associated with a higher risk of cognitive decline and dementia. The study adds evidence that sleep patterns may be relevant to brain health in people living with these conditions, a group already facing elevated risks. Its large participant pool and inclusion of brain scans allow researchers to examine both test performance and brain structure.
The findings may support further research into sleep as a potentially modifiable factor, but they should not be read as proof that better sleep offsets the effects of cardiometabolic disease. The observed cognitive differences were described as slight, and the study was observational. Individual sleep concerns or decisions about managing diabetes, heart disease, stroke, or cognitive health should be discussed with a qualified health professional.
Products Worth Considering
Fitbit Inspire 3 Health and Fitness Tracker Bundle
Oura Ring 4 Smart Ring – Silver – Size 8
Oura Ring 5 Smart Ring – Stealth, Size 11
As an affiliate, we earn on qualifying purchases.
How Researchers Measured Sleep
The report treats type 2 diabetes, heart disease and stroke as cardiometabolic diseases and notes that they are established risk factors for declining cognitive and brain health. Researchers asked whether healthy sleep was associated with better outcomes in people with these diagnoses, rather than testing a sleep treatment.
The study, by Miao and colleagues, was published in 2026 in the Journal of the American Heart Association under the title “Healthy sleep mitigates the association between cardiometabolic disease and poorer cognitive and brain health.” The work was funded by Karolinska Institutet’s strategic research programme in diabetes and several Swedish research and dementia organizations, among others.
“Our findings suggest that healthy sleep may help offset some of the adverse consequences of cardiometabolic disease for the brain.”
— Abigail Dove, researcher at Karolinska Institutet’s Aging Research Center
Causation and Sleep Changes
The report describes an observational analysis based on UK Biobank data and self-reported sleep factors. It does not establish whether healthier sleep led to better cognitive scores or larger brain volumes, whether better health contributed to better sleep, or whether other factors influenced both. The supplied study summary does not give effect sizes for the cognitive or brain-volume differences, so their precise magnitude cannot be assessed here.
It is also unclear from the report whether changing sleep habits would alter brain structure or cognitive performance, or which of the five sleep factors matters most. The findings concern group-level associations and cannot predict an individual’s cognitive health or clinical outcome.
Further Study of Sleep and Risk
The study is now published in the Journal of the American Heart Association. The source report does not identify a planned follow-up, trial or next publication. Further research would be needed to test whether interventions that improve sleep can change cognitive outcomes or brain measures in people with cardiometabolic disease, and to determine how specific sleep patterns relate to those outcomes.
For now, the results offer an observational finding for researchers and clinicians to consider alongside established care for diabetes, heart disease and stroke. They do not replace medical advice or show that sleep changes can prevent dementia.
Key Questions
What did the study find?
Among people with type 2 diabetes, heart disease or stroke, healthier self-reported sleep was associated with slightly better cognitive test performance and larger brain volumes than poorer sleep.
Does the study prove that good sleep protects the brain?
No. It reports an association and does not prove that sleep caused the differences or that improving sleep prevents cognitive decline or dementia.
How was sleep assessed?
Researchers used five self-reported factors: sleep duration, circadian rhythm, insomnia, snoring and daytime sleepiness.
How many people took part?
The analysis included more than 400,000 UK Biobank participants, including just over 54,000 with at least one cardiometabolic disease. MRI scans were available for nearly 35,000 participants.
Should people change their treatment based on the findings?
The study does not test a treatment or provide personal medical guidance. People with sleep or health concerns should speak with a qualified health professional before making medical decisions.
Source: news-medical.net
